Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1976 2
1977 4
1978 2
1979 3
1980 3
1981 5
1982 7
1983 3
1984 7
1985 3
1986 4
1987 4
1988 8
1989 3
1990 5
1991 6
1992 3
1993 8
1994 5
1995 3
1996 3
1997 2
1998 4
1999 2
2000 4
2001 4
2002 4
2003 1
2004 6
2005 7
2006 11
2007 9
2008 3
2009 5
2010 4
2011 3
2012 2
2013 5
2014 4
2015 9
2016 7
2017 6
2018 11
2019 3
2020 4
2021 4
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP).
Sharma P, Kimler BF, O'Dea A, Nye L, Wang YY, Yoder R, Staley JM, Prochaska L, Wagner J, Amin AL, Larson K, Balanoff C, Elia M, Crane G, Madhusudhana S, Hoffmann M, Sheehan M, Rodriguez R, Finke K, Shah R, Satelli D, Shrestha A, Beck L, McKittrick R, Pluenneke R, Raja V, Beeki V, Corum L, Heldstab J, LaFaver S, Prager M, Phadnis M, Mudaranthakam DP, Jensen RA, Godwin AK, Salgado R, Mehta K, Khan Q. Sharma P, et al. Among authors: kimler bf. Clin Cancer Res. 2021 Feb 15;27(4):975-982. doi: 10.1158/1078-0432.CCR-20-3646. Epub 2020 Nov 18. Clin Cancer Res. 2021. PMID: 33208340 Free PMC article. Clinical Trial.
EGFR as a potent CAR T target in triple negative breast cancer brain metastases.
Subham S, Jeppson JD, Worcester C, Schatmeyer B, Zhao J, Madan R, Lakis NS, Kimler BF, McGuirk JP, Chen RC, Stecklein SR, Akhavan D. Subham S, et al. Among authors: kimler bf. Breast Cancer Res Treat. 2023 Jan;197(1):57-69. doi: 10.1007/s10549-022-06783-1. Epub 2022 Nov 1. Breast Cancer Res Treat. 2023. PMID: 36318382 Free PMC article.
Keep your eye on the target<sup/>
Kimler BF. Kimler BF. Int J Radiat Biol. 2018 Aug;94(8):756-758. doi: 10.1080/09553002.2017.1393580. Epub 2017 Nov 6. Int J Radiat Biol. 2018. PMID: 29035121
Combating radiation therapy-induced damage to the ovarian environment.
Duncan FE, Kimler BF, Briley SM. Duncan FE, et al. Among authors: kimler bf. Future Oncol. 2016 Jul;12(14):1687-90. doi: 10.2217/fon-2016-0121. Epub 2016 Apr 27. Future Oncol. 2016. PMID: 27117319 Free PMC article. Review. No abstract available.
Breast-tissue sampling for risk assessment and prevention.
Fabian CJ, Kimler BF, Mayo MS, Khan SA. Fabian CJ, et al. Among authors: kimler bf. Endocr Relat Cancer. 2005 Jun;12(2):185-213. doi: 10.1677/erc.1.01000. Endocr Relat Cancer. 2005. PMID: 15947097 Review.
211 results